These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18095376)

  • 21. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells.
    Huang JH; Tykocinski ML
    Int Immunol; 2001 Apr; 13(4):529-39. PubMed ID: 11282992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the small GTPase Rap1 and extracellular signal-regulated kinases by the costimulatory molecule CTLA-4.
    Dillon TJ; Carey KD; Wetzel SA; Parker DC; Stork PJ
    Mol Cell Biol; 2005 May; 25(10):4117-28. PubMed ID: 15870282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic inhibition of T-cell activation by a cell-permeable ZAP-70 mutant and ctCTLA-4.
    Kim KD; Choi JM; Chae WJ; Lee SK
    Biochem Biophys Res Commun; 2009 Apr; 381(3):355-60. PubMed ID: 19230824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic equilibrium of B7-1 dimers and monomers differentially affects immunological synapse formation and T cell activation in response to TCR/CD28 stimulation.
    Bhatia S; Sun K; Almo SC; Nathenson SG; Hodes RJ
    J Immunol; 2010 Feb; 184(4):1821-8. PubMed ID: 20065109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4.
    Chikuma S; Imboden JB; Bluestone JA
    J Exp Med; 2003 Jan; 197(1):129-35. PubMed ID: 12515820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometry used for the analysis of calcium signaling induced by antigen-specific T-cell activation.
    Réthi B; Detre C; Gogolák P; Kolonics A; Magócsi M; Rajnavölgyi E
    Cytometry; 2002 Apr; 47(4):207-16. PubMed ID: 11933010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyunsaturated fatty acids interfere with formation of the immunological synapse.
    Geyeregger R; Zeyda M; Zlabinger GJ; Waldhäusl W; Stulnig TM
    J Leukoc Biol; 2005 May; 77(5):680-8. PubMed ID: 15703198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.
    Metz DP; Farber DL; Taylor T; Bottomly K
    J Immunol; 1998 Dec; 161(11):5855-61. PubMed ID: 9834064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD2 and TCR synergize for the activation of phospholipase Cgamma1/calcium pathway at the immunological synapse.
    Espagnolle N; Depoil D; Zaru R; Demeur C; Champagne E; Guiraud M; Valitutti S
    Int Immunol; 2007 Mar; 19(3):239-48. PubMed ID: 17220479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular determinants of inverse agonist activity of biologicals targeting CTLA-4.
    Teft WA; Madrenas J
    J Immunol; 2007 Sep; 179(6):3631-7. PubMed ID: 17785798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases.
    Guntermann C; Alexander DR
    J Immunol; 2002 May; 168(9):4420-9. PubMed ID: 11970985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation.
    Baroja ML; Luxenberg D; Chau T; Ling V; Strathdee CA; Carreno BM; Madrenas J
    J Immunol; 2000 Jan; 164(1):49-55. PubMed ID: 10604992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.
    Fife BT; Griffin MD; Abbas AK; Locksley RM; Bluestone JA
    J Clin Invest; 2006 Aug; 116(8):2252-61. PubMed ID: 16886063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CTLA-4 differentially regulates the immunological synapse in CD4 T cell subsets.
    Jackman RP; Balamuth F; Bottomly K
    J Immunol; 2007 May; 178(9):5543-51. PubMed ID: 17442936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of murine CTLA-4 and its role in modulating T cell responsiveness.
    Ostrov DA; Shi W; Schwartz JC; Almo SC; Nathenson SG
    Science; 2000 Oct; 290(5492):816-9. PubMed ID: 11052947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of CTLA-4 in the regulation and initiation of T-cell responses.
    Chambers CA; Krummel MF; Boitel B; Hurwitz A; Sullivan TJ; Fournier S; Cassell D; Brunner M; Allison JP
    Immunol Rev; 1996 Oct; 153():27-46. PubMed ID: 9010718
    [No Abstract]   [Full Text] [Related]  

  • 39. New protein steals the show as 'costimulator' of T cells.
    Cohen J
    Science; 1993 Nov; 262(5135):844-5. PubMed ID: 7694360
    [No Abstract]   [Full Text] [Related]  

  • 40. Relevance of CD6-mediated interactions in T cell activation and proliferation.
    Gimferrer I; Calvo M; Mittelbrunn M; Farnós M; Sarrias MR; Enrich C; Vives J; Sánchez-Madrid F; Lozano F
    J Immunol; 2004 Aug; 173(4):2262-70. PubMed ID: 15294938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.